EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische StudieOpen Access · CC BY 4.0

Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion

Carl J Danzig, Christiana Dinah, Faruque Ghanchi, Lars-Olof Hattenbach, Arshad M Khanani, Timothy Y Y Lai, Masahiko Shimura, Francis Abreu, Pablo Arrisi, Ying Liu, Liliana P Paris, Anne-Cecile Retiere und 3 weitere

Ophthalmology Retina · 2025

DOI: 10.1016/j.oret.2025.03.005 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Ophthalmology Retina, 2025. Verfasst von Carl J Danzig und 14 weiteren Autor:innen. Beteiligte Einrichtung: Rand Eye Institute, Deerfield Beach, Florida; Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida. Electronic ad…. Hauptthemen laut MEDLINE: Retinal Vein Occlusion, Macular Edema, Visual Acuity, Macula Lutea. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: F. Hoffmann-La Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Vein OcclusionMacular EdemaVisual AcuityMacula LuteaHumansDouble-Blind MethodMaleFemaleIntravitreal InjectionsAngiogenesis InhibitorsTomography, Optical CoherenceDose-Response Relationship, DrugFollow-Up StudiesAgedRecombinant Fusion ProteinsTreatment OutcomeMiddle AgedReceptors, Vascular Endothelial Growth FactorTime FactorsVascular Endothelial Growth Factor AFluorescein AngiographyFundus OculiAntibodies, Bispecific

Stichwörter der Autor:innen

Angiopoietin-2FaricimabMacular edema secondary to retinal vein occlusionTreat-and-extendVEGF receptor

Substanzen

Angiogenesis InhibitorsRecombinant Fusion ProteinsReceptors, Vascular Endothelial Growth FactorafliberceptVascular Endothelial Growth Factor AfaricimabAntibodies, Bispecific

Autor:innen und Institutionen

  • Rand Eye Institute, Deerfield Beach, Florida; Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida. Electronic address: carldanzigmd@gmail.com.
  • Ophthalmology Department, London North West University Healthcare NHS Trust, Central Middlesex Hospital, London, United Kingdom; Department of Brain Sciences, Imperial College, London, United Kingdom.
  • Bradford Teaching Hospitals, Bradford, United Kingdom.
  • Department of Ophthalmology, Ludwigshafen Academic Teaching Hospital, Ludwigshafen, Germany.
  • Sierra Eye Associates, Reno, Nevada; Reno School of Medicine, University of Nevada, Reno, Nevada.
  • Department of Ophthalmology and Visual Science, The Chinese University of Hong Kong, Hong Kong, China.

Förderung

  • F. Hoffmann-La Roche

Zitieren

APA

Danzig, C. J., Dinah, C., Ghanchi, F., Hattenbach, L. O., Khanani, A. M., Lai, T. Y. Y., Shimura, M., Abreu, F., Arrisi, P., Liu, Y., Paris, L. P., Retiere, A. C., Willis, J. R., Schlottmann, P. G., & BALATON and COMINO Investigators (2025). Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2025.03.005

Vancouver

Danzig CJ, Dinah C, Ghanchi F, Hattenbach LO, Khanani AM, Lai TYY, et al. Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion. Ophthalmology Retina. 2025. doi:10.1016/j.oret.2025.03.005

BibTeX
@article{Danzig2025,
  author = {Danzig, Carl J and Dinah, Christiana and Ghanchi, Faruque and Hattenbach, Lars-Olof and Khanani, Arshad M and Lai, Timothy Y Y and Shimura, Masahiko and Abreu, Francis and Arrisi, Pablo and Liu, Ying and Paris, Liliana P and Retiere, Anne-Cecile and Willis, Jeffrey R and Schlottmann, Patricio G and BALATON and COMINO Investigators, BALATON and COMINO Investigators},
  title = {Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion},
  journal = {Ophthalmology Retina},
  year = {2025},
  doi = {10.1016/j.oret.2025.03.005}
}
Kostenlos starten →